SITE-SPECIFIC STUDIES PROVIDE STRUCTURAL INFORMATION ON AMYLOID BETA OLIGOMERS
特定位点研究提供了淀粉样β低聚物的结构信息
基本信息
- 批准号:8170990
- 负责人:
- 金额:$ 1.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmyloid beta-ProteinAntibodiesComputer Retrieval of Information on Scientific Projects DatabaseCysteineDisease ProgressionEnvironmentFluorescent DyesFundingGrantHydrophobicityInstitutionLabelMeasuresPatternPeptidesPropertyPublishingResearchResearch PersonnelResourcesRoleSiteSourceStructureUnited States National Institutes of Healthabeta accumulationabeta oligomeracrylodanbaseguanidine thiocyanateinterestneurotoxicityresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Aggregation of Abeta peptides is a major contributor to Alzheimer's disease. Oligomeric forms of these peptides are especially interesting due to their high neurotoxicity and potentially important role in disease progression. However, very little structural information is currently available on Abeta oligomers. We have previously established that Abeta oligomers can be divided into at least two structural classes (prefibrillar and fibrillar oligomers) based on their reactivity with conformational antibodies. Here we compared both site-specific and global conformational stability of Abeta 40 fibrils and both classes of oligomers. To measure the site-specific stability, we introduced cysteine residues throughout the sequence of Abeta 40, labeled the new cysteines with the fluorescent dye acrylodan, and investigated their environment within the aggregates in guanidine thiocyanate-induced denaturation experiments. We found that Abeta 40 fibrils show high stability towards denaturation and moderate hydrophobicity in the 15-35 region with the exception of residues 25-30. This pattern is consistent with previously published structures of Abeta 40 fibrils. Fibrillar oligomers show similar pattern consistent with our hypothesis that they represent fragments of protofibrils. However, prefibrillar oligomers show lower stability towards denaturation and more hydrophobic environment throughout the 15-35 region of the peptide. Distinct conformational properties of prefibrillar oligomers may explain their differential recognition by conformational antibodies and serve as a basis for their neurotoxicity.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
Abeta多肽的聚集是阿尔茨海默病的主要原因。这些多肽的低聚形式特别令人感兴趣,因为它们具有很高的神经毒性,并可能在疾病进展中发挥重要作用。然而,目前关于Abeta寡聚体的结构信息很少。我们先前已经确定,根据与构象抗体的反应性,Aβ寡聚体可以至少分为两种结构类型(前纤维低聚物和纤维低聚物)。在这里,我们比较了Abeta40纤维和这两类低聚物的特定位置和整体构象稳定性。为了测量位点特异性稳定性,我们在Abeta40的整个序列中引入半胱氨酸残基,用荧光染料acryloan标记新的半胱氨酸,并在硫氰酸胍诱导的变性实验中研究它们在聚集体中的环境。我们发现,除25-30残基外,Abeta40纤维在15-35区域表现出高度的变性稳定性和中等的疏水性。这一模式与之前发表的Abeta40纤维的结构一致。纤维状低聚物表现出类似的模式,与我们的假设一致,即它们代表原纤维的碎片。然而,前纤维状低聚物在多肽的15-35区域表现出较低的变性稳定性和更疏水的环境。前纤维状低聚物独特的构象特性可能解释了它们被构象抗体区别识别的原因,并作为它们神经毒性的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles G. Glabe其他文献
Amyloid Oligomers Increase the Lifetime and Single Channel Conductance of Gramicidin Channels
- DOI:
10.1016/j.bpj.2009.12.1527 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Yuri Sokolov;Saskia C. Milton;Charles G. Glabe;James E. Hall - 通讯作者:
James E. Hall
Amyloid Oligomers Increase the Lifetime and Single Channel Conductance of Gramicidin Channels
- DOI:
10.1016/j.bpj.2010.12.2034 - 发表时间:
2011-02-02 - 期刊:
- 影响因子:
- 作者:
Yuri V. Sokolov;Saskia C. Milton;Charles G. Glabe;James E. Hall - 通讯作者:
James E. Hall
Die spezifische Zellerkennung
特殊的泽勒肯农
- DOI:
10.1002/ciuz.19940280111 - 发表时间:
1994 - 期刊:
- 影响因子:0.8
- 作者:
A. Hofmann;Charles G. Glabe - 通讯作者:
Charles G. Glabe
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
撤回文章:大脑中一种特定的淀粉样β蛋白聚集体损害记忆
- DOI:
10.1038/nature04533 - 发表时间:
2006-03-16 - 期刊:
- 影响因子:48.500
- 作者:
Sylvain Lesné;Ming Teng Koh;Linda Kotilinek;Rakez Kayed;Charles G. Glabe;Austin Yang;Michela Gallagher;Karen H. Ashe - 通讯作者:
Karen H. Ashe
Amyloid Oligomers Alter The Conductance Of The Gramicidin Channel
- DOI:
10.1016/j.bpj.2008.12.719 - 发表时间:
2009-02-01 - 期刊:
- 影响因子:
- 作者:
Yuri V. Sokolov;Saskia C. Milton;Charles G. Glabe;James E. Hall - 通讯作者:
James E. Hall
Charles G. Glabe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles G. Glabe', 18)}}的其他基金
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD
共享资源开发工具和试剂来研究 AD 中 Abeta 淀粉样蛋白聚集体的结构多态性
- 批准号:
10706566 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD
共享资源开发工具和试剂来研究 AD 中 Abeta 淀粉样蛋白聚集体的结构多态性
- 批准号:
10549101 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Temporal, Spatial and Cellular Dynamics of Amyloid Plaque Deposition
淀粉样蛋白斑沉积的时间、空间和细胞动力学
- 批准号:
10525630 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Structure and conformational diversity of amyloid oligomers
淀粉样蛋白寡聚物的结构和构象多样性
- 批准号:
8235899 - 财政年份:2010
- 资助金额:
$ 1.8万 - 项目类别:
Structure and conformational diversity of amyloid oligomers
淀粉样蛋白寡聚物的结构和构象多样性
- 批准号:
8445260 - 财政年份:2010
- 资助金额:
$ 1.8万 - 项目类别:
Structure and conformational diversity of amyloid oligomers
淀粉样蛋白寡聚物的结构和构象多样性
- 批准号:
8053831 - 财政年份:2010
- 资助金额:
$ 1.8万 - 项目类别:
STRUCTURE & CONFORMATIONAL DIVERSITY OF AMYLOID AGGREGATES BY FCS
结构
- 批准号:
8170964 - 财政年份:2010
- 资助金额:
$ 1.8万 - 项目类别:
Structure and conformational diversity of amyloid oligomers
淀粉样蛋白寡聚物的结构和构象多样性
- 批准号:
7897965 - 财政年份:2010
- 资助金额:
$ 1.8万 - 项目类别:
STRUCTURE & CONFORMATIONAL DIVERSITY OF AMYLOID AGGREGATES BY FCS
结构
- 批准号:
7956535 - 财政年份:2009
- 资助金额:
$ 1.8万 - 项目类别:
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain
AD 脑中淀粉样蛋白积累机制/发病机制
- 批准号:
6587293 - 财政年份:2002
- 资助金额:
$ 1.8万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 1.8万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 1.8万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 1.8万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 1.8万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 1.8万 - 项目类别:














{{item.name}}会员




